NCT01194167 Study of Eltrombopag in Platelet Refractory Thrombocytopenia Status WITHDRAWN Phase PHASE2
NCT01165996 Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome Status COMPLETED Phase PHASE1/PHASE2
NCT01163110 Study to Investigate the Therapeutic Role of RNA Fragments in Platelet Production During Chemotherapy Status COMPLETED Phase PHASE1
NCT01162941 Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP) Status UNKNOWN Phase PHASE2
NCT01153919 Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia Status TERMINATED Phase PHASE2
NCT01002755 Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Status COMPLETED Phase PHASE2
NCT00961064 A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE2
NCT00948792 Study of the Effect of Differing Platelet Transfusion Times in Neonates Status COMPLETED Phase NA
NCT00922883 A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients Status COMPLETED Phase PHASE2
NCT00909363 Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients Status TERMINATED Phase PHASE2
NCT00907478 Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP) Status COMPLETED Phase PHASE4
NCT00903929 Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation Status COMPLETED Phase PHASE1
NCT00771810 Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT00748878 Platelet Function During ECMO (Extra Corporeal Membrane Oxygenation) Status COMPLETED Phase N/A
NCT00735930 Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Status COMPLETED Phase PHASE1
NCT00730314 Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells Status COMPLETED Phase PHASE1/PHASE2